⌘K

Login Start Free

Home/Filings/4/0001179110-21-009149

4//SEC Filing

MULLEN JAMES C 4

Accession 0001179110-21-009149

CIK 0001650664other

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:20 PM ET

Size

4.7 KB

Accession

0001179110-21-009149

Insider Transaction Report

Form 4

Period: 2021-09-30

Editas Medicine, Inc.EDIT

Director

Transactions

Award
Common Stock
2021-09-30+36,478→ 71,478 total

Footnotes (1)

[F1]Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on March 2, 2021.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

IncorporatedMA

Related Parties

1

filerCIK 0001226288

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 4:20 PM ET
Size: 4.7 KB

View on SEC.gov